Reported about 2 months ago
Source: INVESTORS
Reported about 2 months ago
Hims & Hers Health's stock dropped significantly after Eli Lilly announced the release of a lower-priced version of its weight-loss drug Zepbound. Lilly's new offering, which allows users to measure doses themselves and is sold directly to consumers, poses fresh competition for Hims & Hers, which has been selling its own copycat injectable drugs like Wegovy and Ozempic. Following the news, Hims & Hers shares fell by 7% but are still up nearly 70% year-to-date.
Source: YAHOO
Reported about 2 months ago
Hindenburg Research has revealed a short position in Super Micro Computer, alleging accounting manipulations and significant governance issues. The report claims evidence of undisclosed transactions and non-compliance with export controls, causing Super Micro's stock to drop 3.5% in morning trading. Despite benefiting from the AI boom, Super Micro faces mounting competition and pressure on profit margins, leading to concerns over its financial practices.
Source: YAHOO
Reported about 2 months ago
Pfizer has launched a new telehealth and prescription drug platform, marking its entry into the direct consumer health market, following a similar initiative by competitor Eli Lilly earlier this year. The platform aims to enhance consumer access to prescription medications and vaccines through strategic partnerships.
Source: YAHOO
Reported about 2 months ago
In August, Americans' confidence in the job market decreased despite an overall rise in consumer confidence, according to data from the Conference Board. The consumer confidence index rose from 101.9 to 103.3, but concerns about the labor market increased, with fewer people viewing jobs as plentiful. This dip in optimism coincides with a recent unemployment rate increase and softened labor market conditions, leading economists to closely watch upcoming job reports.
Source: YAHOO
Reported about 2 months ago
Source: BARRONS
Reported about 2 months ago
The tech sector faces pressure as investors await Nvidia's earnings, raising concerns about meeting market expectations. However, Seema Shah of Principal Asset Management notes that strong earnings are beginning to spread beyond Big Tech, indicating a healthier economic outlook. She emphasizes that a diverse performance across sectors is crucial for a robust equity market, suggesting that current trends could be interpreted as 'good news' for future growth.
Source: YAHOO
Reported about 2 months ago
NVIDIA is set to release its fiscal Q2 2025 earnings on August 28, and anticipation is building around its ETFs such as the Strive U.S. Semiconductor ETF and VanEck Vectors Semiconductor ETF. While NVIDIA has seen an 18.7% increase in stock value recently, forecasts suggest a 33.3% jump in earnings and 109% growth in revenue for the upcoming quarter. Analysts remain optimistic, highlighting robust demand for AI technologies, although there are concerns regarding potential delays in the release of new AI chips.
Source: YAHOO
Reported about 2 months ago
Apple is set to launch its iPhone 16 on September 9, but analysts warn that the anticipation of its AI software, Apple Intelligence, may delay consumer purchases. Maxim Group's Tom Forte points out that while new hardware will be available, the lack of AI updates could deter customers, potentially impacting short-term sales.
Source: YAHOO
Reported about 2 months ago
Super Micro Computer shares fell over 2% following a report by Hindenburg Research claiming the company engages in 'accounting manipulation' and highlighting serious governance issues. The report points to undisclosed related party transactions and prior accounting violations, suggesting a pattern of non-compliance. Despite recently experiencing significant growth driven by AI, the company faces increased scrutiny and competition in the market.
Source: YAHOO
Reported about 2 months ago
John Foley, the former CEO of Peloton, shared how he lost his billionaire status as the company's stock plummeted after the pandemic. He revealed that he sold most of his possessions, including a $55 million home, while Peloton's market value fell from $50 billion to $1.8 billion. Despite this financial turmoil, Foley remains optimistic and is launching a new venture, Ernesta, hoping to regain financial stability.
Source: YAHOO
Reported about 2 months ago
Eli Lilly has introduced a new, more affordable version of its obesity drug Zepbound to help those without insurance access the medication. The new pricing includes a 2.5 mg single-dose vial at $399 per month and a four-week supply of the 5 mg dose for $549, which is significantly lower than the previous cost of around $1,000 per month. However, these doses will be sold in vials requiring a syringe and needle instead of the injector pens used for more expensive doses.
Source: YAHOO
Reported about 2 months ago
Marathon Digital's shares dropped after JPMorgan cut its price target from $14 to $12, attributing the change to fluctuations in bitcoin prices and network hash rates that could impact miner profitability.
Source: YAHOO
Reported about 2 months ago
Source: WSJ
Reported about 2 months ago
Lip-Bu Tan, an Intel board member, has resigned due to differences with CEO Pat Gelsinger and other directors regarding the company's workforce size, risk-averse culture, and AI strategy. Tan expressed frustration with Intel's approach and underscored the challenges the company faces in its turnaround efforts, which have left it vulnerable amid rising competition in the semiconductor industry.
Source: YAHOO
Reported about 2 months ago
Investors are keenly awaiting Nvidia's Q2 earnings report set to release on August 28, with expectations of a staggering 109% increase in earnings and a 99% rise in revenue year-over-year. Analysts are questioning if the semiconductor giant can meet these high expectations, with potential implications for its stock and the broader market.
Source: YAHOO
Reported about 2 months ago
Source: BARRONS
Reported about 2 months ago
Hindenburg Research has announced that it is shorting shares of Super Micro Computer (SMCI), leading to a decline in the stock's value during early trading on Tuesday.
Source: YAHOO
Reported about 2 months ago
In August, US consumer confidence rose significantly to 103.3, surpassing expectations of 100.7, as reported by the Conference Board. This increase highlights positive economic sentiment among consumers, which has implications for stock market reactions.
Source: YAHOO
Reported about 2 months ago
Paramount stock fell over 7% after the company confirmed the end of its 'go-shop' period and billionaire Edgar Bronfman Jr. withdrew his bid to purchase the company. With Skydance Media set to take ownership, Paramount anticipates closing the $8 billion deal in early 2025, while facing challenges such as a $6 billion write-down in the cable unit and plans to cut 15% of its workforce.
Source: YAHOO
Reported about 2 months ago
Investing in AI stocks is gaining traction as companies leverage AI to enhance productivity. According to Wall Street analysts, CrowdStrike and Nvidia are two notable stocks poised for growth. Despite recent challenges for CrowdStrike, analysts see a significant upside potential, while Nvidia's soaring demand for AI chips indicates a promising future. With strong projections for both companies, this is an opportune moment for investors.
Source: YAHOO
Reported about 2 months ago
Eli Lilly has announced significant price reductions for its weight-loss drug Zepbound, lowering the monthly cost to $399 for the 2.5mg dose and $549 for the 5mg dose, down from the original $1,060 price. This decision comes as part of a strategy to enhance accessibility amidst the ongoing GLP-1 medication shortages. The new pricing aligns with the company's aim to target caregivers and patients paying out-of-pocket, particularly through its LillyDirect platform. The changes reflect Lilly's efforts to maintain market dominance in the competitive weight-loss drug segment.
Source: YAHOO
Reported about 2 months ago
Cava's stock experienced a decline in pre-market trading on Tuesday following disclosures from CEO Brent Schulman and other executives regarding stock sales. Schulman sold over 210,000 shares for approximately $24.87 million, while other executives, including the Chief Concept Officer and CFO, also sold significant amounts of their holdings.
Source: YAHOO
Reported about 2 months ago
US stocks faced minor declines on Tuesday following a record high in the Dow the previous day. Investors are cautiously awaiting Nvidia's pivotal earnings report, which could influence tech stocks amid declining semiconductor values. Simultaneously, anticipation builds for a significant reading on the inflation gauge favored by the Federal Reserve, potentially affecting predictions of an interest rate cut next month.
Source: YAHOO
Reported about 2 months ago
With Apple's CFO transition set for January 1, 2025, from Luca Maestri to Kevan Parekh, the new CFO will face significant challenges, including ongoing antitrust lawsuits, increased regulation, and rising competition, particularly in China. While expectations remain that Parekh will continue Maestri's approach of enhancing shareholder value, there is speculation about a potential future leadership change for CEO Tim Cook, which could have greater implications for investors.
Source: YAHOO